Copyright
©2014 Baishideng Publishing Group Inc. All rights reserved.
World J Gastroenterol. Dec 21, 2014; 20(47): 18059-18060
Published online Dec 21, 2014. doi: 10.3748/wjg.v20.i47.18059
Published online Dec 21, 2014. doi: 10.3748/wjg.v20.i47.18059
Hepatocellular carcinoma review: Current treatment, and evidence-based medicine
Bulent Karaman, Bilal Battal, Sebahattin Sari, Samet Verim, Gata Radiology Department, 06291 Ankara, Turkey
Author contributions: Karaman B and Battal B wrote the letter; Sari S and Verim S revised the letter.
Correspondence to: Bulent Karaman, MD, Gata Radiology Department, General tevfik saglam cd GATA hastanesi ETLIK, 06291 Ankara, Turkey. bulkaraman@yahoo.com
Telephone: +90-312-3044735 Fax: +90-312-3044707
Received: May 14, 2014
Revised: June 17, 2014
Accepted: July 15, 2014
Published online: December 21, 2014
Processing time: 220 Days and 19.5 Hours
Revised: June 17, 2014
Accepted: July 15, 2014
Published online: December 21, 2014
Processing time: 220 Days and 19.5 Hours
Core Tip
Core tip: We read with great interest the recent article entitled “Hepatocellular carcinoma review: Current treatment, and evidence-based medicine” by Raza et al, published in World Journal of Gastroenterology. Authors evaluated treatments for early and advanced stage hepatocellular carcinoma based on an extensive review of the relevant literature. They reported that radiofrequency ablation is the most effective local ablative therapy. They concluded that radiofrequency ablation is equivalent to surgical resection in well selected patients with early stage hepatocellular carcinoma. In addition, we want to mention microwave ablation besides RF ablation.